DK99987D0 - Oestrogenpraeparater - Google Patents

Oestrogenpraeparater

Info

Publication number
DK99987D0
DK99987D0 DK099987A DK99987A DK99987D0 DK 99987 D0 DK99987 D0 DK 99987D0 DK 099987 A DK099987 A DK 099987A DK 99987 A DK99987 A DK 99987A DK 99987 D0 DK99987 D0 DK 99987D0
Authority
DK
Denmark
Prior art keywords
estrogen preparations
estrogen
compound
preparations
medication
Prior art date
Application number
DK099987A
Other languages
English (en)
Other versions
DK99987A (da
DK174892B1 (da
Inventor
Roger Boissoneault
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK99987D0 publication Critical patent/DK99987D0/da
Publication of DK99987A publication Critical patent/DK99987A/da
Application granted granted Critical
Publication of DK174892B1 publication Critical patent/DK174892B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK198700999A 1986-02-27 1987-02-26 Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis DK174892B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83426386A 1986-02-27 1986-02-27
US83426386 1986-02-27

Publications (3)

Publication Number Publication Date
DK99987D0 true DK99987D0 (da) 1987-02-26
DK99987A DK99987A (da) 1987-08-28
DK174892B1 DK174892B1 (da) 2004-01-26

Family

ID=25266516

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198700999A DK174892B1 (da) 1986-02-27 1987-02-26 Anvendelse af en kombination af ethinyløstradiol og norethindronacetat til fremstilling af et farmaceutisk præparat til behandling af osteoporosis

Country Status (12)

Country Link
EP (1) EP0235090B1 (da)
JP (1) JP2942560B2 (da)
AT (1) ATE94392T1 (da)
AU (1) AU599082B2 (da)
CA (1) CA1300017C (da)
DE (1) DE3787386T2 (da)
DK (1) DK174892B1 (da)
ES (1) ES2059403T3 (da)
HK (1) HK182795A (da)
MY (1) MY101855A (da)
NL (1) NL300004I1 (da)
ZA (1) ZA87332B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61236B1 (en) † 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
AU640112B2 (en) * 1989-11-03 1993-08-19 Warner-Lambert Company Estrogen and progestogen containing oral dosage forms
US5591753A (en) * 1994-01-28 1997-01-07 Eli Lilly And Company Combination treatment for osteoporosis
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor

Also Published As

Publication number Publication date
AU599082B2 (en) 1990-07-12
JPS62205024A (ja) 1987-09-09
DE3787386T2 (de) 1994-05-05
HK182795A (en) 1995-12-08
DK99987A (da) 1987-08-28
DE3787386D1 (de) 1993-10-21
JP2942560B2 (ja) 1999-08-30
ZA87332B (en) 1987-08-26
AU6913087A (en) 1987-09-03
ES2059403T3 (es) 1994-11-16
ATE94392T1 (de) 1993-10-15
MY101855A (en) 1992-01-31
DK174892B1 (da) 2004-01-26
CA1300017C (en) 1992-05-05
NL300004I1 (nl) 2000-04-03
EP0235090A1 (en) 1987-09-02
EP0235090B1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
EP0242643A3 (en) Nasal administration of drugs
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
AU7061687A (en) Pharmaceutical composition for treating periodontal diseases
GR3005035T3 (da)
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
GB8725631D0 (en) Bipolar transistor
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
DK99987D0 (da) Oestrogenpraeparater
DE3750067D1 (de) Disazoverbindungen und diese Disazoverbindungen enthaltende Zubereitungen.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
IL74138A (en) 4,6,6a,7,8,12b-hexahydro-indolo(4,3-ab)phenanthridines,their production and pharmaceutical compositions containing them
GB8607749D0 (en) Compounds & pharmaceutical preparations
FR2598617B1 (fr) Composition pharmaceutique
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
PT83984A (en) Process for the preparation of novel 16,17-acetalsubstituted pregnane 21-oic derivatives and of pharmaceutical compositions containing the same
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
GB8610314D0 (en) Bipolar transistor
ZA858194B (en) 3,4-diazole derivatives,processes for their preparation and pharmaceutical preparations containing these compounds
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
DE3676097D1 (de) 15(r)-5-fluorprostazykline und diese verbindungen enthaltende arzneimittel.
DE3852245D1 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel.
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK